BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 22310633)

  • 1. Clinical characteristics and outcomes of renal transplantation in elderly recipients.
    Nanmoku K; Matsuda Y; Yamamoto T; Tsujita M; Hiramitsu T; Goto N; Katayama A; Watarai Y; Kobayashi T; Uchida K
    Transplant Proc; 2012 Jan; 44(1):281-3. PubMed ID: 22310633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eight years of outcomes of the Dutch Living Donor Kidney Exchange Program.
    de Klerk M; Kal-van Gestel JA; Haase-Kromwijk BJ; Claas FH; Weimar W;
    Clin Transpl; 2011; ():287-90. PubMed ID: 22755421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney transplantation in the US: an analysis of the OPTN/UNOS registry.
    Freitas MC
    Clin Transpl; 2011; ():1-16. PubMed ID: 22755397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent immunosuppression for ABO-incompatible renal transplantation may not be a risk factor for malignancy.
    Yamamoto T; Kawaguchi T; Watarai Y; Tujita M; Hiramitsu T; Nanmoku K; Goto N; Katayama A; Kobayashi T; Uchida K
    Transplant Proc; 2012 Jan; 44(1):210-3. PubMed ID: 22310616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of pediatric ABO-incompatible kidney transplantations are equivalent to ABO-compatible controls.
    Shishido S; Hyodo YY; Aoki Y; Takasu J; Kawamura T; Sakai KK; Aikawa AA; Satou H; Muramatsu MM; Matsui Z
    Transplant Proc; 2012 Jan; 44(1):214-6. PubMed ID: 22310617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excellent outcomes of ABO-incompatible kidney transplantation: a single-center experience.
    Uchida J; Kuwabara N; Machida Y; Iwai T; Naganuma T; Kumada N; Nakatani T
    Transplant Proc; 2012 Jan; 44(1):204-9. PubMed ID: 22310615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor-recipient age difference and graft survival in living donor kidney transplantation.
    Lee YJ; Chang JH; Choi HN; Jung JY; Kim YS; Chung WK; Park YH; Lee HH
    Transplant Proc; 2012 Jan; 44(1):270-2. PubMed ID: 22310630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of blood group A2-to-O liver transplantation: an analysis of the United Network of Organ Sharing database.
    Kluger MD; Guarrera JV; Olsen SK; Brown RS; Emond JC; Cherqui D
    Transplantation; 2012 Sep; 94(5):526-31. PubMed ID: 22874840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial chimerism after ABO-incompatible kidney transplantation.
    Tanabe T; Ishida H; Horita S; Honda K; Yamaguchi Y; Nonomura K; Tanabe K
    Transplantation; 2012 Apr; 93(7):709-16. PubMed ID: 22456486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of ABO compatibility on outcomes after heart transplantation in a national cohort during the past decade.
    Jawitz OK; G Jawitz N; Yuh DD; Bonde P
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1239-45; discussion 1245-6. PubMed ID: 23978472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival and allograft rejection rates after combined heart and kidney transplantation in comparison with heart transplantation alone.
    Czer LS; Ruzza A; Vespignani R; Jordan S; De Robertis MA; Mirocha J; Gallagher SP; Patel K; Schwarz ER; Kass RM; Trento A
    Transplant Proc; 2011 Dec; 43(10):3869-76. PubMed ID: 22172862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of renal transplantation after end-stage renal disease due to diabetic nephropathy: a single-center experience.
    Tokodai K; Amada N; Kikuchi H; Haga I; Takayama T; Nakamura A
    Transplant Proc; 2012 Jan; 44(1):77-9. PubMed ID: 22310584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utilization and advantages of an exchange donor program in living donor renal transplantation: a single-center experience.
    Kim HS; Kwon OJ; Kang CM
    Transplant Proc; 2012 Jan; 44(1):14-6. PubMed ID: 22310566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidneys from older living donors provide excellent intermediate-term outcomes after transplantation.
    Balachandran VP; Aull MJ; Charlton M; Afaneh C; Serur D; Leeser DB; Del Pizzo J; Kapur S
    Transplantation; 2012 Sep; 94(5):499-505. PubMed ID: 22892992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results with expanded donor acceptance criteria in heart transplantation.
    Forni A; Luciani GB; Chiominto B; Pizzuti M; Mazzucco A; Faggian G
    Transplant Proc; 2011 May; 43(4):953-9. PubMed ID: 21620025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Better actual 10-year renal transplant outcomes of 80% reduced cyclosporine exposure with sirolimus base therapy compared with full cyclosporine exposure without or with concomittant sirolimus treatment.
    Pliszczynski J; Kahan BD
    Transplant Proc; 2011 Dec; 43(10):3657-68. PubMed ID: 22172822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed graft function after renal transplantation: an unresolved problem.
    Gavela Martínez E; Pallardó Mateu LM; Sancho Calabuig A; Beltrán Catalán S; Kanter Berga J; Ávila Bernabeu AI; Crespo Albiach J
    Transplant Proc; 2011; 43(6):2171-3. PubMed ID: 21839224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Present status of ABO-incompatible kidney transplantation in Japan.
    Takahashi K; Saito K
    Xenotransplantation; 2006 Mar; 13(2):118-22. PubMed ID: 16623804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
    Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A
    Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney transplantation at Tokyo Women's Medical University.
    Inui M; Ishida H; Omoto K; Tanabe T; Hattori M; Hirano H; Tanabe K
    Clin Transpl; 2011; ():127-43. PubMed ID: 22755409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.